The World of Health & Medicine News

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

Adtalem, Google Cloud to launch AI credential program for healthcare professionals

Adtalem Global Education (ATGE.N), opens new tab said on Wednesday it will partner with Alphabet’s (GOOGL.O), opens new tab Google Cloud to launch an artificial intelligence credential program aimed at students and healthcare professionals to use AI tools in clinical practice.

The program, set to debut in 2026, will provide students and practicing clinicians across Adtalem’s network, including Chamberlain University and Walden University, with hands-on experience using Google Cloud’s AI tools, such as Gemini models and Vertex AI services.

Adtalem said participants will complete coursework covering AI applications in clinical practice, ethical considerations, patient safety protocols, and hands-on experience with healthcare-specific AI tools commonly used across hospital systems and clinical practices.

The initiative comes as hospitals invest heavily in AI to ease staffing shortages, but many physicians and nurses remain unprepared to adopt the technology, said the healthcare educator, which serves more than 91,000 students across its institutions, and has around 365,000 alumni.

Michael Betz, Adtalem’s chief digital officer, said the “partnership with Google Cloud gives our students a competitive edge in their careers — whether they’re treating patients, providing mental health counseling, or leading healthcare teams.”

He added, “our graduates will enter the workforce confident in using AI to enhance their clinical decisions, spend less time on paperwork and more time connecting with patients.”

Brent Mitchell, vice president of Google Public Sector, said the partnership aims to ensure clinicians can implement AI “safely, responsibly and effectively.”

A Harris poll from last month showed more than half of U.S. healthcare workers are actively looking to leave their current jobs.

The survey also showed 42% of employees worry AI will replace some aspects of their job, with 41% or less than half feeling comfortable using AI tools in their current role.

spot_img

Explore more

spot_img

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...

Women are increasingly using steroids — despite these 7 major risks

Women are increasingly using steroids — despite these 7 major risks As fitfluencers push powerlifting, weight training and “whatever it takes” to get toned, more women...

Kyverna’s cell therapy helps patients improve mobility in mid-stage trial

Kyverna's cell therapy helps patients improve mobility in mid-stage trial Kyverna Therapeutics said its experimental cell therapy met the main goal of “significantly” improving patients’...

AstraZeneca, Daiichi’s breast cancer drug gets FDA nod as first-line treatment

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment The U.S. Food and Drug ​Administration has approved ‌Daiichi Sankyo's therapy in combination ‌with...

WHO expert group’s new analysis reaffirms there is no link between...

WHO expert group’s new analysis reaffirms there is no link between vaccines and autism new analysis from a WHO global expert committee on vaccine safety...

US FDA expands use of GSK’s Blujepa as treatment for gonorrhea

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use...

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal The World Health Organization chief said on Thursday that he was still hoping the U.S. administration...